122 related articles for article (PubMed ID: 30672672)
1. [The main metabolites ferrokinetics in differential diagnostic of anemic syndrome with microcytic, hypochromic characteristics of erythrocytes in patients with colorectal cancer.].
Blindar VN; Zubrikhina GN; Matveeva II
Klin Lab Diagn; 2018; 63(2):89-94. PubMed ID: 30672672
[TBL] [Abstract][Full Text] [Related]
2. [The main metabolites of ferrokinetics in differentiated diagnostic of anemic syndrome].
Blindar VN; Zubrikhina GN; Matveeva II
Klin Lab Diagn; 2016 Apr; 61(4):219-23. PubMed ID: 30586240
[TBL] [Abstract][Full Text] [Related]
3. [Development of strategic approaches to modern diagnosis of anemic syndrome in patients with breast cancer.].
Blindar VN; Zubrikhina GN; Davydova TV; Somonova OV; Elizarova AL; Dobrovolskaya MM; Kharitidi TY; Lyubimova NV; Kushlinsky NE; Bobryshev AA; Kononenko IB; Snegovoy AV
Klin Lab Diagn; 2019; 64(4):210-215. PubMed ID: 31108032
[TBL] [Abstract][Full Text] [Related]
4. Assessment of iron metabolism disorders and adequate treatment of anemic syndrome in patients with breast cancer on the background of adjuvant chemotherapy.
Blindar VN; Zubrikhina GN; Davydova TV; Dobrovolskaya MM; Khagazheeva MN; Snegovoy AV; Lyubimova NV; Kushlinskii NE; Ryabchikov DA
Klin Lab Diagn; 2022 Apr; 67(4):213-218. PubMed ID: 35575394
[TBL] [Abstract][Full Text] [Related]
5. [The characteristics of anemic syndrome in patients with prevalent phases of Hodgkin lymphoma before treatment].
Zubrikhina GN; Blindar VN; Matveeva II; Demina EA
Klin Lab Diagn; 2015 Feb; 60(2):28-32. PubMed ID: 26027256
[TBL] [Abstract][Full Text] [Related]
6. [THE DIFFERENTIAL DIAGNOSTIC POSSIBILITIES IN EVALUATION OF IRON-DEFICIENT CONDITION UNDER ANEMIAS].
Zubrikhina GN; Blindar VN; Matveeva II
Klin Lab Diagn; 2016 Mar; 61(3):144-50. PubMed ID: 27506105
[TBL] [Abstract][Full Text] [Related]
7. Iron deficient erythropoiesis might play key role in development of anemia in cancer patients.
Park S; Jung CW; Kim K; Kim SJ; Kim WS; Jang JH
Oncotarget; 2015 Dec; 6(40):42803-12. PubMed ID: 26517509
[TBL] [Abstract][Full Text] [Related]
8. [The possibilities of modern automated clinical blood analysis in differentiated diagnostic of true and redistributing (functional) iron deficiency under anemic syndrome in oncologic patients].
Zubrikhina GN; Blinder VN; Matveyeva II
Klin Lab Diagn; 2014 May; (5):21-5. PubMed ID: 25338459
[TBL] [Abstract][Full Text] [Related]
9. Study of the hepcidin level in pregnant women with and without anemia.
Aringazina R; Mussina A; Zholdassova N; Seitmaganbetova N; Gubasheva G
Acta Biomed; 2023 Feb; 94(1):e2023021. PubMed ID: 36786257
[TBL] [Abstract][Full Text] [Related]
10. [The algorithm of modern laboratory diagnostics of anemic syndrome in oncologic patients].
Blindar' VN; Zubrikhina GN; Matveeva II
Klin Lab Diagn; 2012 Jul; (7):19-24. PubMed ID: 22988797
[TBL] [Abstract][Full Text] [Related]
11. [Searching for additional markers of impaired iron metabolism in diabetes mellitus].
Musina NN; Saprina TV; Prokhorenko TS; Zima AP
Probl Endokrinol (Mosk); 2020 Aug; 66(2):61-70. PubMed ID: 33351349
[TBL] [Abstract][Full Text] [Related]
12. Cross sectional, comparative study of serum erythropoietin, transferrin receptor, ferritin levels and other hematological indices in normal pregnancies and iron deficiency anemia during pregnancy.
Sharma JB; Bumma SD; Saxena R; Kumar S; Roy KK; Singh N; Vanamail P
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():99-103. PubMed ID: 27267870
[TBL] [Abstract][Full Text] [Related]
13. Markers of iron status in chronic kidney disease.
Gaweda AE
Hemodial Int; 2017 Jun; 21 Suppl 1(Suppl 1):S21-S27. PubMed ID: 28328097
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis.
Shu T; Jing C; Lv Z; Xie Y; Xu J; Wu J
Eur J Haematol; 2015 Jan; 94(1):67-73. PubMed ID: 24954786
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
16. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing anemia in inflammatory bowel disease: beyond the established markers.
Oustamanolakis P; Koutroubakis IE; Kouroumalis EA
J Crohns Colitis; 2011 Oct; 5(5):381-91. PubMed ID: 21939910
[TBL] [Abstract][Full Text] [Related]
18. Serum hepcidin in inflammatory bowel diseases: biological and clinical significance.
Bergamaschi G; Di Sabatino A; Albertini R; Costanzo F; Guerci M; Masotti M; Pasini A; Massari A; Campostrini N; Corbella M; Girelli D; Corazza GR
Inflamm Bowel Dis; 2013 Sep; 19(10):2166-72. PubMed ID: 23867871
[TBL] [Abstract][Full Text] [Related]
19. NCOA4 Deficiency Impairs Systemic Iron Homeostasis.
Bellelli R; Federico G; Matte' A; Colecchia D; Iolascon A; Chiariello M; Santoro M; De Franceschi L; Carlomagno F
Cell Rep; 2016 Jan; 14(3):411-421. PubMed ID: 26776506
[TBL] [Abstract][Full Text] [Related]
20. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index.
Skikne BS; Punnonen K; Caldron PH; Bennett MT; Rehu M; Gasior GH; Chamberlin JS; Sullivan LA; Bray KR; Southwick PC
Am J Hematol; 2011 Nov; 86(11):923-7. PubMed ID: 21812017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
